These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28259898)

  • 21. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
    Yamada M; Li AW; West KA; Chang CH; Wall JR
    Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocytes resided in the thyroid are the main source of TSH-receptor antibodies in Basedow's-Graves' disease?
    Leövey A; Nagy E; Balazs G; Bako G
    Exp Clin Endocrinol; 1992; 99(3):147-50. PubMed ID: 1526264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Diagnostic Utility of Color Doppler Ultrasonography, Tc-99m Pertechnetate Uptake, and TSH-Receptor Antibody for Differential Diagnosis of Graves' Disease and Silent Thyroiditis: A Comparative Study.
    Zuhur SS; Ozel A; Kuzu I; Erol RS; Ozcan ND; Basat O; Yenici FU; Altuntas Y
    Endocr Pract; 2014 Apr; 20(4):310-9. PubMed ID: 24246346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with thyroglobulin induces Graves'-like disease in mice.
    Endo T; Kobayashi T
    J Endocrinol; 2009 Aug; 202(2):217-22. PubMed ID: 19491147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of natural killer T cells in Graves' disease.
    Luo W; Guo H; Aosai F; Yano A
    Chin Med J (Engl); 2002 Aug; 115(8):1183-5. PubMed ID: 12215288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice.
    Aliesky HA; Pichurin PN; Chen CR; Williams RW; Rapoport B; McLachlan SM
    Endocrinology; 2006 Jun; 147(6):2789-800. PubMed ID: 16543368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Long-Term Inorganic Iodine on Intrathyroidal Iodothyronine Content and Gene Expression in Mice with Graves' Hyperthyroidism.
    Uchida T; Shimamura M; Taka H; Kaga N; Miura Y; Nishida Y; Nagayama Y; Watada H
    Thyroid; 2023 Mar; 33(3):330-337. PubMed ID: 36565031
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
    Costagliola S; Many MC; Denef JF; Pohlenz J; Refetoff S; Vassart G
    J Clin Invest; 2000 Mar; 105(6):803-11. PubMed ID: 10727449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves' disease.
    He K; Hu Y; Xu XH; Mao XM
    Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):368-72. PubMed ID: 24941434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Murine model of Graves disease induced by thyroid-stimulating hormone receptor gene transfected via liposome].
    Long W; Qiu LH; Meng C; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):550-5. PubMed ID: 23286397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
    Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on protective effects and mechanisms of total glucosides of Paeony on Graves disease in BALB/c mice].
    Wu LP; Xie BS; Wang JY; DeJi JCM; Zhao FY; Ding X; Liu XJ; Lin XY; Zhou XC; Zhao Y; Wu Q; Shi BY
    Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(9):689-695. PubMed ID: 36858370
    [No Abstract]   [Full Text] [Related]  

  • 38. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
    Meller J; Jauho A; Hüfner M; Gratz S; Becker W
    Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The usefulness of thyroid size and TSH receptor antibody (TRAb) determinations in predicting the effectiveness of tiamazole and I-131 treatment for Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):242-7. PubMed ID: 15314993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.